Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations

被引:185
作者
Bess, JW
Gorelick, RJ
Bosche, WJ
Henderson, LE
Arthur, LO
机构
[1] AIDS Vaccine Program, SAIC, Natl. Cancer Inst.-Frederick C., Frederick
关键词
D O I
10.1006/viro.1997.8499
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Identification and quantitation of cellular proteins associated with HIV-1 particles are complicated by the presence of nonvirion-associated cellular proteins that copurify with virions. Many cellular proteins are associated with nonviral particles that bud from the surface of cells called microvesicles. Microvesicles band in sucrose gradients in a range of densities that includes the same density as retroviruses. To characterize these microvesicles, HIV-1-infected and uninfected human T-cell lines were propagated and Virus and microvesicles were purified from clarified cell culture supernatants by sucrose density gradient centrifugation or centrifugation through 20% sucrose pads. Microvesicles were found to contain Various proteins, including HLA DR and beta 2-M, and a substantial amount of RNA and DNA The concentrations of HIV-1 p24(CA), HLA DR, and beta 2-microglobulin (beta 2-M) were determined by radioimmunoassay. The ratios of HIV-1 p24(CA) to HLA DR and beta 2-M were found to vary with respect to the HIV-1 isolate, host cell, and other factors. Electron microscopic analysis of microvesicles revealed that they consisted of particles of various sizes and morphologies. Although HIV-1 particles are known to contain some cellular proteins, microvesicles from HIV-1 infected H9 cells appeared to contain little or no HIV-1 gp120(SU). (C) 1997 Academic Press.
引用
收藏
页码:134 / 144
页数:11
相关论文
共 46 条
[1]   MACAQUES IMMUNIZED WITH HLA-DR ARE PROTECTED FROM CHALLENGE WITH SIMIAN IMMUNODEFICIENCY VIRUS [J].
ARTHUR, LO ;
BESS, JW ;
URBAN, RG ;
STROMINGER, JL ;
MORTON, WR ;
MANN, DL ;
HENDERSON, LE ;
BENVENISTE, RE .
JOURNAL OF VIROLOGY, 1995, 69 (05) :3117-3124
[2]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[3]  
Ausubel FM, 1995, CURRENT PROTOCOLS MO
[4]   TIGHTLY BOUND ZINC IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I, AND OTHER RETROVIRUSES [J].
BESS, JW ;
POWELL, PJ ;
ISSAQ, HJ ;
SCHUMACK, LJ ;
GRIMES, MK ;
HENDERSON, LE ;
ARTHUR, LO .
JOURNAL OF VIROLOGY, 1992, 66 (02) :840-847
[5]   HLA ANTIBODIES IN BLOOD-DONORS WITH REACTIVE SCREENING-TESTS FOR ANTIBODY TO THE IMMUNODEFICIENCY VIRUS [J].
BLANTON, M ;
BALAKRISHNAN, K ;
DUMASWALA, U ;
ZELENSKI, K ;
GREENWALT, TJ .
TRANSFUSION, 1987, 27 (01) :118-119
[6]   Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses [J].
Braaten, D ;
Franke, EK ;
Luban, J .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4220-4227
[7]   HIV TYPE-1 GROWN ON INTERFERON GAMMA-TREATED U937 CELLS SHOWS SELECTIVE INCREASE IN VIRION-ASSOCIATED INTERCELLULAR-ADHESION MOLECULE-1 AND HLA-DR AND ENHANCED INFECTIVITY FOR CD4-NEGATIVE CELLS [J].
CASTILLETTI, C ;
CAPOBIANCHI, MR ;
FAIS, S ;
ABBATE, I ;
FICOCIELLO, B ;
AMEGLIO, F ;
FEI, PC ;
SANTINI, SM ;
DIANZANI, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :547-553
[8]  
CHAN WL, 1995, AIDS, V9, P223, DOI 10.1097/00002030-199509030-00002
[9]  
DAVIS LG, 1986, BASIC METHODS MOL BI, P130
[10]   HLA-ANTIGEN CONTAMINATION OF COMMERCIAL WESTERN BLOT STRIPS FOR DETECTING HUMAN IMMUNODEFICIENCY VIRUS [J].
DRABICK, JJ ;
BAKER, JR .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) :357-358